Pharmaceutical Sales and Marketing Articles

Panic or Perform

You receive a voice-mail message from senior leadership, which contains the same thing you've heard from your manager for months: "Stay focused! Don't worry about things you can't control. You are our most important resource. We are the right size to compete in today's market." Before you hang up or listen halfheartedly in disbelief, what should you do? Trust is tenuous in trying times.

Author(s): 
Orlando Ceaser
Journal: 
Pharmaceutical Representative, Jan 1, 2009

InVentiv Approaches

Welcome to Success Stories, which explores what makes the industry's top-performing representatives so amazingly successful.

Author(s): 
Sarah Taylor
Journal: 
Pharmaceutical Representative, Jan 1, 2009

Moving on Up

DIAGNOSIS
Winning the election to office provides opportunities to propel your career to even higher levels or bring it to a screeching halt

PRESCRIPTION
Create an intentional impression and action plan for success

Author(s): 
Jean (Mowrey) Male
Journal: 
Pharmaceutical Representative, Dec 1, 2008

A Bigger, Bolder Agency

When a salmonella contamination hit pistachio nuts a few months ago, FDA moved quickly to recall products and shut down processors. These days, officials are sending out more warning letters, as well as taking bolder enforcement actions and a more proactive approach to health emergencies such as swine flu.

Author(s): 
Jill Wechsler
Journal: 
Pharmaceutical Executive, Jun 1, 2009

High School Justice

My wife says I extrapolate too much from my own adolescence. She's undoubtedly right, but I still think my high school taught me at least one useful lesson about law enforcement: Left to their own devices, the enforcers will punish the relatively innocent and spare the truly guilty. Why? Well, obviously because it's so much easier to punish the relatively innocent. They're well-behaved.

Author(s): 
Patrick Clinton
Journal: 
Pharmaceutical Executive, Jun 1, 2009

Domestic Intervention

While the current recession consumes the lion's share of intellectual energy on the part of politicians, industry leaders, and academics, it may also obscure a larger, more systemic problem. The state of US education has fallen so far behind other industrialized nations that it now threatens to alter our way of life.

Author(s): 
Sander A. Flaum
Journal: 
Pharmaceutical Executive, Jun 1, 2009

Compensation Overkill

When calamity strikes, Americans tend to look for a villain. This is how we regulate our industries, keep our government honest, and even how we go to war. Unfortunately, it means that many policies forged in haste end up being repealed years later, when it's clear that they were the result of overreaction.

Author(s): 
Sander A. Flaum
Journal: 
Pharmaceutical Executive, May 1, 2009

Another Dimension

When our publisher, Jay Berfas, first came to Pharm Exec, he brought with him a fat black portfolio. We all learned what was inside when Jay gathered the editorial team around a table and poured out three decades' worth of 3-D memorabilia—magazine covers, ads, photos, and dozens of pairs of red-and-blue glasses.

Author(s): 
Patrick Clinton
Journal: 
Pharmaceutical Executive, May 1, 2009

Compared to What?

Jill Wechsler

Author(s): 
Jill Wechsler
Journal: 
Pharmaceutical Executive, May 1, 2009

The Fate of Mannkind

Let's get one thing straight right up front: We're not talking about inhaled insulin. Sure, it comes out of an inhaler; yes, you breathe it in; and of course it's absorbed deep in the lungs. But please don't use those two unfortunate words. Inhaled insulin was a misguided idea—an attempt to replace needles and injections with something ostensibly more convenient.

Author(s): 
Cassandra Blohowiak, contributing editor
Journal: 
Pharmaceutical Executive, May 1, 2009
Syndicate content